Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal contracts (SAM.gov)The Ultimate Guide to SAM.gov Registration
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to answer an RFPChoosing and Responding to Government Bids
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›A--Recipient Epidemiology and Donor Evaluation Study

U.S. Department Of Health And Human Services·Maryland

A--Recipient Epidemiology and Donor Evaluation Study

Closes 3/16/2026$500k – $2MRequest for Proposal
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The National Institutes of Health (NIH) is seeking a Data Coordinating Center (DCC) for the Recipient Epidemiology and Donor Evaluation Study. The DCC will be responsible for coordinating the study's data collection and analysis. The study aims to evaluate the epidemiology of recipients and donors. Key aspects of the job include: • Coordinating data collection and analysis for the study • Collaborating with other study sites and stakeholders • Ensuring data quality and integrity • Providing technical support and expertise to the study team Our client should consider their experience in data coordination, epidemiology, and study management when evaluating this opportunity.

Attached files

The solicitation documents live at the source — open the bid source above to download them.

Contact

Kelli B. Malkin

[email protected]

(301) 435-0332

Key dates

Opened
5/16/2025
Closes
3/16/2026

Last updated

Details

Type
Request for Proposal
Industry
Healthcare and Medical Services
NAICS
541715
Solicitation №
75N92025R00026

Budget estimate

$500,000 – $2,000,000

The budget for this opportunity is likely to be in the range of $500,000 to $2 million, considering the scope of the study and the role of the Data Coordinating Center. The study's complexity, the number of study sites, and the duration of the study are factors that may influence the likely payment range. However, this is a rough estimate, and the actual budget may vary depending on the specifics of the proposal and the NIH's budget.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 73%

Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)

Closes 7/5/2029Opened 6/16/2025

Mississippi Department of Health·Mississippi

71% match

Cancer Survivorship Evaluation

Closes 11/2/2026Opened 10/13/2026

U.S. National Institutes of Health·United States of America

71% match

Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 CT Not Allowed)

Closes 10/20/2028Opened 7/8/2025

U.S. National Institutes of Health·United States of America

71% match

Clinical Trials in Organ Transplantation in Children and Adults

Closes 9/29/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

71% match

Translational Transplantation Tolerance Cooperative Study Group

Closes 5/20/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

71% match

Implementation and Evaluation of Databases to Examine AIDS

Closes 5/26/2027Opened 5/27/2025

U.S. National Institutes of Health·United States of America

70% match

HEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional)

Closes 2/9/2029Opened 6/4/2026

U.S. National Institutes of Health·United States of America

70% match

Immune Tolerance Network (UM1 Clinical Trial Required)

Closes 1/29/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

70% match

Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)

Closes 11/9/2026Opened 1/29/2026

U.S. National Institutes of Health·United States of America

70% match

Integrated Specific Pathogen Free Research Models and Human New Approach Methodologies to Advance HIV/AIDS Research (U42 Clinical Trial Not Allowed)

Closes 1/24/2027Opened 5/20/2026

U.S. National Institutes of Health·United States of America

69% match

Accelerating Discovery through Partnered Research with All of Us to Analyze Participant Biospecimens (X01 Clinical Trial Not Allowed)

Closes 3/1/2027Opened 1/8/2026

U.S. National Institutes of Health·United States of America

69% match

Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 eSubmission Clinical Trial Optional)

Closes 9/7/2028Opened 1/6/2025

U.S. National Institutes of Health·United States of America

69% match

Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)

Closes 11/18/2026Opened 10/30/2023

U.S. National Institute of Justice·United States of America

69% match

NIJ FY 2026 Research and Evaluation on Human Trafficking

Closes 11/16/2026Opened 10/9/2026

U.S. National Institutes of Health·United States of America

69% match

Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed)

Closes 12/14/2026Opened 5/12/2025

U.S. Defense Health Agency Contracting Activity - DHACA·United States of America

69% match

DoW Reconstructive Transplant, Investigator-Initiated Research Award

Closes 11/4/2026Opened 8/4/2026

U.S. Indian Health Service·United States of America

69% match

Tribal Epidemiology Centers

Closes 6/30/2027Opened 8/6/2026

U.S. National Institutes of Health·United States of America

69% match

Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)

Closes 11/10/2026Opened 11/18/2025

U.S. Centers for Disease Control - NCBDDD·United States of America

69% match

Surveillance and Case Control Study of Stillbirth and Birth Defects (SUCCSSBD)

Closes 4/29/2027Opened 8/17/2026

U.S. National Institutes of Health·United States of America

69% match

NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)

Closes 7/5/2029Opened 6/27/2025

U.S. National Institutes of Health·United States of America

69% match

NIH Brain Development Cohorts (NBDC) and�Population Assessment of Tobacco and Health (PATH) Study�Biospecimen Access (X01 Clinical Trial Not Allowed)

Closes 4/17/2029Opened 9/10/2025

U.S. National Institutes of Health·United States of America

69% match

Centers for Research on Neglected Infectious Diseases

Closes 6/14/2027Opened 10/6/2026

U.S. National Institutes of Health·United States of America

69% match

Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)

Closes 11/2/2026Opened 11/6/2023

U.S. National Institutes of Health·United States of America

69% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: Tissue Procurement Center (R24 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

69% match

NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed)

Closes 7/5/2029Opened 7/8/2025